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Abstract
Background To investigate the natural history and the
growth rate of spheno-orbital meningiomas (SOMs).
Methods Ninety patients with a diagnosis of SOM were
included, and patient charts and imaging were evaluated. In
a subset of 32 patients, volumetric studies were performed.
Results The median follow-up for the entire group was
4 years (range, 1–15); the mean age was 47.8 (range,
26–93) years; 94% of the patients were female. The most
common clinical signs and symptoms were proptosis
(93%), visual deterioration (65%), retro-bulbar pain (23%)
and diplopia (6%). In 35% of patients in this series, no
visual deterioration occurred, and in 30% only mild
proptosis was present. The median annual growth rate of
the SOMs in the subset of 32 patients was 0.3 cm3/year
(range, 0.03–1.8 cm3/year). We assessed a trend for more
rapid tumour growth in younger patients and found the
initial volume of the tumour (rho=0.63) and of the soft
tissue component (rho=074) to be significantly related to
the growth rate.
Conclusion SOMs are slow-growing tumours that cause
primarily proptosis and visual deterioration. In a significant
number of patients, these tumours cause minimal discom-
fort and symptomatology. Therefore, in the absence of risk
factors, we advocate a “wait and see” policy. For patients
with large SOMs or with a large soft tissue component at
first visit or with fast growing SOMs (>1cm3/year), a
follow-up examination every 6 months is indicated.
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Introduction
Spheno-orbital meningiomas (SOMs) are secondary
tumours of the orbit that originate from the dura of the
sphenoid wing bone. They exhibit interosseous tumour
growth, leading to hyperostosis and a thin, carpet-like soft
tissue growth at the dura [11, 17]. The most common signs
and symptoms associated with SOMs are visual deteriora-
tion, proptosis, and cosmetic deformity.
The biological behaviour of SOMs varies. In some
patients, minor symptoms are present whereas in others a
devastating loss of vision, severe proptosis, and disfiguring
due to rapid growth is observed [1, 4, 5, 11, 12, 14–17, 19].
Surgical treatment of these tumours is associated with a
high morbidity and a mortality rate of up to 6%. In
addition, the recurrence rate of SOMs is higher than that of
meningiomas in other locations [1, 4, 5, 11, 12, 14–17, 19].
The majority of published studies on SOMs concern results
of the surgical treatment of these tumours. Little informa-
tion is available on the natural history of the tumours and
the outcomes for patients who do not undergo surgical
intervention.
In this study, we analysed clinical characteristics,
imaging results, and annual growth of SOMs prior to any
intervention except biopsy in patients diagnosed with SOM.
Patients and methods
We examined the records of 90 patients seen between 1980
and 2008 at the Orbital Centre of the Academic Medical
Centre, University of Amsterdam (n=61), and at the
University Medical Center in Utrecht (n=29). Patients with
nonhyperostotic sphenoid wing meningiomas, clinoid
meningiomas, or primary optic nerve sheath meningiomas
were excluded from this study.
All patients underwent ophthalmological examinations
to assess visual acuity (Snellen notation). Colour vision was
determined quantitatively by dividing the total number of
Ishihara plates correctly identified by the total number of
plates tested. Ocular motility was also assessed. Diplopia
was considered present when the patient experienced
double vision (in any gaze direction) that disappeared with
one eye closed. The degree of proptosis was determined
using a Hertel exophthalmometer. In Amsterdam, an
Oculus Hertel (Oculus Optikgeräte GmbH, Wetzlar, Ger-
many) was used and in Utrecht, a Zeiss Hertel (Carl Zeiss,
Jena, Germany) was used. However, in each patient, always
the same instrument was used.
Funduscopy and evaluation of the optic disc were
performed on all patients. Because perimetry examinations
to assess visual field were not performed in all patients, we
did not include these examinations in our analysis.
All patients underwent detailed neurological examina-
tions. All 90 patients underwent computed tomography, and
75 also underwent magnetic resonance imaging (MRI). We
documented the extent of hyperostosis and involvement of
the optic canal (OC), superior orbit fissure (SOF), and
infraorbital fissure. Gadolinium-enhanced and fat-
suppressed MRI sequences were obtained in three planes
to analyse the extent of infiltration of the dura mater,
intracranial extension, and intra- and extraconal orbital and
periorbital involvement. We had histopathologic material
available in 77 patients: 66 from debulking surgery in a
later stage and 11 from biopsies.
From the late 1990s onwards, all SOM patients
underwent MRI studies; thus, serial MRI studies of 32
consecutive patients were available. Volumetric measure-
ments were performed only on these patients. In this group,
the volume (V) and annual growth rate (AGR) of each SOM
prior to any intervention were measured using at least two
follow-up MRI scans. The calculations were performed on
enhanced axial T1 slices of 1.3 to 6 mm sing Scion Image J
software developed at the US National Institutes of Health.
The enhanced area of the tumour in each slice image was
measured by manual tracing of the tumour boundaries. The
sum of the enhanced areas was then multiplied by the slice
interval of the MRI series to obtain the total tumour
volume. Dura mater, bone, and soft tissue were included in
the measurements. Soft tissue component was also mea-
sured separately.
AGR values in cubic centimetres per year (cm3/year)
were determined using the following formula:
AGR ¼ dV ðlatest initialÞ½ 
t
where dV (latest—initial) is the difference in volume (in
cm3/year) between the most recent and initial imaging
studies, and t is the time (in years) of the follow-up period.
Statistical analysis
Patient characteristics and variables are described as
mean or median with range where appropriate. Differ-
ences in continuous or categorical variables between
groups were analyzed using the Wilcoxon–Mann–Whitney or
Fisher’s exact test, respectively. Spearman’s correlation
coefficients were calculated between the tumour growth and
age, the volume of tumour, soft tissue component at the first
diagnosis, and the length of the follow-up period. For all tests,
probability values of less than 0.05 were considered to
indicate statistical significance. All analyses were carried
out using the Statistical Package for Social Sciences
(SPSS software version 16 for Windows; SPSS, Inc.,
Chicago, IL).
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Results
The mean age of the patients was 47.8 years (range, 26–
93). There were 85 (94%) females and five (6%) males. In
49 patients the right orbit was involved and in 41 patients
the left orbit was involved. The most common co-morbidity
was thyroid dysfunction. In all, three patients were
hypothyroid and 11 patients were hyperthyroid, three of
whom also had Graves’ orbitopathy. Six patients had a
history of breast cancer. Café au lait spots were observed in
two patients, and one patient had been diagnosed with
neurofibromatosis type 2.
Median follow-up for the entire group was 4 years
(range, 1–15). Median follow-up was 2 years (range, 0–12)
for the group that eventually underwent surgery and 7 years
(range, 3–15) for the group that was observed only.
Signs and symptoms
We documented 39 patients (41%) with an initial visual
acuity in the affected eye of 0.8 or better. Three patients
(3%) presented with no light perception in the affected eye.
The presenting visual acuity is summarised in Table 1.
In all, 29 patients had optic discs with some degree of
disc atrophy, 28 presented with disc oedema, and 33 had
normal discs. (Figure 1). Choroidal folds were present in
only three patients. With the exception of six patients, the
majority (93%) of the patients in this series exhibited
proptosis as measured by the Hertel exophthalmometer.
Mean proptosis difference between the affected and
contralateral eye at presentation was 5.5 mm (range, 0–
14) for all patients. With regard to other signs and
symptoms, five patients (6%) exhibited diplopia at presen-
tation, and one patient presented with diplopia after 2 years
of follow-up. Generalised headaches and focal retro-orbital
pain were observed in 21 patients (23%). No patients died
because of SOM.
Imaging
We analysed images of the 75 patients with both a
computed tomography scan and at least one MRI.
Eighteen patients (24%) exhibited more than one intra-
cranial meningioma. All patients showed involvement of
the sphenoid wing, dura mater, and the orbit. (Figure 2).
Fifty-seven patients (76%) had some intracranial soft
tissue component and 39 (52%) were intraorbital, ten of
which were intraconal. Fifty-four patients (72%) had
SOMs that involved the periorbit, and 52 meningiomas
extended into the orbital roof. A total of 68 tumours
involved the SOF, 56 involved the OC, 29 involved the
infraorbital fissure, and 30 extended into the anterior
clinoid process. Nine tumours invaded the cavernous sinus
(Fig. 2; Table 1).
Patients Percent Significant deterioration Surgery
N=90 N=75
VA
1.0–0.8 39 41 8 18
0.7–0.4 27 30 27 27
0.3–CF 23 26 18 18
NLP 3 3 0 3
Proptosis (mm)
0–1 6 7 0 0
2–4 28 23 7 12
5–10 49 54 12 47
10–14 7 8 1 7
Location (imaging)
Dura 75 100 NA NA
Periorbit 70 93 NA NA
SOF 68 91 NA NA
OC 60 80 NA NA
Orbital roof 52 70 NA NA
Anterior clinoid 30 40 NA NA
IOF 29 39 NA NA
Cavernous sinus 12 16 NA NA
Intraconal 8 11 NA NA
Table 1 Signs and imaging
characteristics of spheno-orbital
meningiomas
VA visual acuity, TX treatment,
OZ orbitozygomatic resection,
NA not applicable, OC optic
canal, SOF superior orbit fissure
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Natural history and progression
Volumetric studies
Our cohort for volumetric studies consisted of 32 patients.
The mean age at presentation was 48 years (range, 37–69).
All patients were female. The median follow-up period was
9.3 years (range, 4–28). The average initial tumour volume
was 6.9 cm3 (range, 1.8–13.60), and the median annual
growth rate was 0.3 cm3/year (range, 0.03–1.8). Although a
trend for faster growth in younger patients was present, the
difference was not statistically significant (rho=0.171;
p=0.346). AGR was significantly positively correlated with
volume of soft tissue component (rho=0.714) and the initial
tumour volume (rho=0.633). AGR increased with increas-
ing initial tumour volume; however this relationship was
not linear (Fig. 2). Six SOMs in this series had an AGR of
more than 1 cm3/year (range, 1.10–1.8). All of these
tumours had a large soft tissue of more than 40% of
volume. (Figure 3)
Characteristics of visual deterioration
To assess the natural history prior to treatment, we analysed
the effect of the tumour on visual acuity in patients
managed with observation alone.
In the entire group 31 patients (35%) maintained a visual
acuity of 0.8 or better in the affected eye during follow-up
(mean, 4.8 years; median, 4 years). Within this group, 22
patients were followed for 5–13 years, and 15 patients were
followed for 3 years (Fig. 4).
Overall, 59 (65%) patients (eyes) developed optic
neuropathy. Five eyes in this series went blind without
any intervention; three of them had had no light perception
at the time of presentation. Each of these five patients was
known to have longstanding optic neuropathy caused by
stenosis of the OC. The approximate mean time between
the diagnosis of optic neuropathy by the ophthalmologist
and assessable deterioration of vision was 38 months
(range, 14–50).
Compression of the optic nerve caused by OC stenosis
was most commonly associated with visual deterioration
and was the most common cause of disc oedema and
atrophy, occurring in 55 out of 59 patients (92%). However,
OC involvement (hyperostosis) was not always associated
with visual deterioration. In patients who had no visual
deterioration, the percentage of OC involvement was 65.8%
whereas in patients with visual deterioration, it was 85.3%.
This difference was not statistically significant (p=0.235).
Although there was a correlation between visual deteriora-
tion and amount of proptosis, the correlation was not
significant (p=0.145). Four patients exhibited opticopathy
with measured proptosis of 10–14 mm. Upon imaging, this
group of patients showed no involvement of the OC.
Characteristics of proptosis
Twenty-seven patients (30%) maintained a proptosis of less
than 4 mm in a median follow-up period of 4 years (range,
3–15 years). (Figure 5) Only seven patients underwent
surgery because of disfiguring proptosis without any visual
deterioration. For the group of patients who eventually
underwent surgery, mean proptosis was 5.89 mm (range,
0–14). The proptosis did not differ in the group who
underwent eventually surgery and observation group
(p=0.102)
There was also no correlation between age and visual
deterioration and amount of proptosis.
Discussion
In this study SOM occurred exclusively in females (94%).
This female predominance is much higher than for other
locations of meningiomas. Optic nerve sheath meningiomas
have a female incidence of 80% [13, 18].
Fig. 1 a Fundus photograph with optic disc edema. b Humphrey visual fields demonstrates inferior arcuate defects in the same patient
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Thyroid dysfunction was the most common association
with SOM in these series (16%). It is possible that
combination of thyroid disease and proptosis has facilitated
the early imaging.
SOMs cause tumour growth, leading to significant
hyperostosis and a thin yet widespread soft tissue growth
at the dura. Bony tumour growth can include the
sphenoid, orbital roof, SOF, OC, and the anterior clinoid
[17, 19]. Some authors have differentiated between
meningioma en plaque (a carpet-like growing tumour)
and hyperostoting meningioma [2, 3]. More recently,
however, MRI has revealed that these tumours represent
a single entity [1, 4, 5, 12, 14–17, 19]. MRI has also
revealed soft tissue involvement in the intracranial region,
the orbital content, the infratemporal fossa, and the
temporal muscle [17, 19]. In this study, the majority of
patients (76%) had some intracranial soft tissue compo-
nent or intraorbital component (39%).
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Fig. 3 Scatter plot showing the distribution of the annual growth and
initial tumour volume
Fig. 2 Gadolinium-enhanced axial T1-weighted MR fat suppression sequence obtained in a patient a with a large SOM consisting of soft tissue, b
mainly with hyperostosis, c cavernous sinus extension, and d growing over the midline
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The causes of hyperostosis in meningiomas are theorised
to include vascular disturbances of the bone caused by the
tumour, irritation of the bone without actual invasion,
previous trauma, the production of bone by the tumour
itself, and the stimulation of osteoblasts in normal bone by
factors secreted by tumour cells. The most accepted cause
of hyperostosis associated with SOM is direct tumour
invasion, which could explain the disproportionate amount
of hyperostosis relative to the dural size of the tumour
[9, 10]. In our series, hyperostosis was present in 100% of
sphenoid wings, 70% of orbital roofs, 91% of SOFs, and
80% of OCs.
In this study, 35% of patients showed no visual
deterioration after a follow-up period of up to 13 years.
Unilateral visual deterioration was encountered in 65% of
patients, generally because of optic nerve compression, not
necessarily because of hyperostosis in the canal. The
incidence of proptosis in this series was 95%, with a mean
of 5.5 mm. Earlier studies reported incidence levels of
proptosis between 33% and 86% [12, 16, 17, 19]. The high
incidence of proptosis in our series can be explained by the
fact that all of the patients had periodic Hertel exophthal-
mometry measurements. Even in patients with no clinically
visible proptosis, proptosis can be identified radiographi-
cally [5]. These findings indicate that proptosis is the most
common clinical sign of SOM. In a significant number of
patients, proptosis may be the only clinical sign. Hyperos-
tosis of the orbital walls, periorbital tumour invasion,
intraorbital tumour, and venous stasis due to compression
of the ophthalmic vein can all lead to proptosis. Diplopia
was not a frequently encountered sign of SOM despite the
fact that upon imaging 91% of patients had extension of
meningioma into the SOF.
Most meningiomas are slow-growing tumours. How-
ever, the precise growth rate is difficult to assess [6].
Some SOMs grow slowly or seemingly not at all when
assessed by planimetric measurement. Volumetric mea-
surement may be a more accurate method of measure-
ment, as tumours may grow in directions different from
the planimetric axes [6–8, 20]. A total of 32 SOMs in our
series exhibited an annual growth rate of 0.3 cm3/year.
Fig. 5 a This 52-year-old woman presented with proptosis. b
Gadolinium-enhanced axial T1-weighted MR fat suppression se-
quence obtained in this patient showed an SOM with hyperostosis.
Proptosis and the SOM on imaging showed no progression during
6 years of follow-up
Fig. 4 Follow-up plot with the individual patients plotted against the age at the start and the end of the follow-up period. a Patients grouped by
surgery, and b patients grouped by the presence of proptosis (prop) and visual impairment
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The growth rate of SOMs is comparable with asymptom-
atic meningiomas [6–8, 20]. SOMs often become symp-
tomatic because of their proximity to the orbit and visual
system.
Although SOMs are slow-growing tumours, some
meningiomas grow much faster than others. In our
series, there was a 60-fold difference between the fastest
and slowest growing SOMs. Although SOMs have a
tendency to grow more slowly in older patients, the
initial size of the tumour and of the soft tissue
component volume were the only statistically significant
predictor of its growth. It is possible that the soft tissue
component itself may grow more rapidly than the
hyperostotic portion of the tumour.
In conclusion, SOMs are slow-growing tumours, but
SOMs with larger volumes and larger soft tissue component
have faster growth rates. The most common sign of SOM in
this study was proptosis (93%) followed by visual
deterioration (65%). In 35% of patients in this series, no
visual deterioration occurred, and in 30% only mild
proptosis was present despite a considerable follow-up
period. In a significant number of patients, SOM remains
mild; therefore, an annual follow-up examination with
ophthalmologic evaluation and MRI is indicated for most
patients. For patients with faster growing SOMs (>1 cm3/
year), larger SOMs with large soft tissue component, or OC
involvement, a follow-up examination every 6 months is
indicated. Although SOMs are slow-growing tumours, in
this series the mean age at diagnosis was 47.8 years and with
many more years to live some SOMs may grow regrettably
large in these patients preventive surgery is indicated.
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Comment
In their interesting review the Authors demonstrated that SOM are
slowly growing tumours, as only six of the 32 patients undergoing
MRI-based volumetric studies exhibited an AGR more than 1 cm3/
year. However, only 35% of their whole series encountered no
visual deterioration during the follow-up period. Moreover, since a
diagnosis of optic neuropathy is made, assessable visual deteriora-
tion will occur within 38 months (range, 14–50). This occurred in
55 out of 59 patients who progressed to disc oedema and atrophy. I
fully agree that for patients with fast growing SOM, large soft
tissue component, or optic neuropathy, surgical intervention is
indicated. Actually, in their series the median follow-up was 2 years
for the group that eventually underwent surgery, and this is an
expression of a clear surgical attitude.
Domenico d’Avella
Padova, Italy
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Cushing, in the 1938 compilation of his intracranial meningiomas,
unforgettably demonstrated how large meningioma can grow and how
it will eventually appear inside and outside the skull in populations
totally uncovered by non-invasive neuroradiology—including the
spheno-orbital meningioma (SOM) with monstrous exophthalmus
and pterional bulge [1].
The authors present a series of 90 SOMs between 1980 and 2008
in two Dutch centers, with serial MRI data for volume growth rate in
32 cases. SOMs are rare (three per year in the present series) but many
patients will come back for re-growth or re-consideration for the next
20 to 30 years. They authors are to be congratulated from placing an
experienced ophthalmologist as the first author—proptosis and
impaired visual acuity are the two leading symptoms [2]—and II–VI
cranial nerve deficits quite frequent after surgical removal even in
experienced hands [2]. Importantly, no visual deterioration occurred in
35% and only mild proptosis was present in 30% despite a
considerable follow-up period—indicating a significant window for
conservative treatment and follow-up only in these cases. Also
importantly, a major soft tissue component indicated faster growth
than a carpet of tissue over the hyperostotic sphenoid bone. The
median follow-up was 2 years for those who eventually underwent
surgery and 7 years for those observed only. Still, meningiomas are
unpredictable, and from a mean age of 48 years at first diagnosis there
are 40 more years to live and to grow.
Juha E Jääskeläinen
Kuopio, Finland
1. Cushing H, Eisenhardt L (1938) Meningiomas: Their Classifi-
cation, Regional Behavior, Life History and Surgical and Results.
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2. Ringel F, Cedzich C, Schramm J. Microsurgical technique and
results of a series of 63 spheno-orbital meningiomas. Neurosurgery
2007;60(4 Suppl 2):214–21; discussion 221–2.
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